Quest Diagnostics | DGX - Selling And Administration Expenses


Quest Diagnostics reported $504M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Acadia Healthcare USD 82.69M 3.6M Mar/2026
Agilent USD 465M 11M Mar/2026
Baxter International USD 728M 33M Mar/2026
Bruker USD 242.1M 5.1M Mar/2026
Cardinal Health USD 1.51B 6M Mar/2026
Centene USD 3.4B 27M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Cigna USD 3.32B 291M Mar/2026
Community Health Systems USD 10.13B 32.48B Mar/2026
Concord Medical Services Hldg CNY 140.37M 36.24M Jun/2025
Danaher USD 1.86B 166M Mar/2026
DaVita Healthcare Partners USD 421.91M 50.45M Mar/2026
Elevance Health USD 10.91B 309M Dec/2025
Encompass Health USD 58.2M 10.2M Mar/2026
HCA USD 39.49B 116.72B Mar/2026
Henry Schein USD 809M 1000K Mar/2026
Humana USD 3.36B 614M Mar/2025
Illumina USD 272M 11M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Laboratory Of America USD 551M 12.4M Mar/2026
McKesson USD 1.8B 234M Mar/2026
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Molina Healthcare USD 3.77B 2.43B Mar/2026
Owens Minor USD 258.98M 7.5M Dec/2025
Pediatrix Medical Group USD 65.68M 4.89M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Tenet Healthcare USD 2.22B 2.12B Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
UnitedHealth USD 15.22B 1.44B Sep/2025
Universal Health Services USD 426.54M 3.78M Mar/2026
Veradigm USD 27.28M 5.24M Dec/2022
Waters USD 394M 153.99M Mar/2026
Zoetis USD 588M 31M Mar/2026